Xy018

Q: How does xy018 compare to similar analytical instruments in the research market?

xy018 by WuXi AppTec distinguishes itself through advanced precision and targeted research capabilities. While alternatives exist from providers like Bio-Techne and Merck Group, xy018 offers superior performance in molecular analysis with enhanced sensitivity and reproducibility.

Q: What are the correct citation details for xy018 in scientific publications?

When referencing xy018, use the following citation protocol: Catalog Number XY018, Manufacturer WuXi AppTec, with full product designation. Include lot number and specific batch information to ensure precise scientific traceability.

Q: What laboratory systems and research platforms are compatible with xy018?

xy018 demonstrates broad compatibility with complementary research compounds including gsk805, tak828f, and other WuXi AppTec molecular platforms. It integrates seamlessly with standard high-throughput screening and analytical research environments.

Q: What primary research domains utilize xy018?

xy018 is predominantly utilized in pharmacological research, drug discovery, molecular biology, and advanced screening protocols. Its versatility makes it particularly valuable in oncology, neuroscience, and metabolic disease research frameworks.

Q: What unique scientific insight is associated with xy018?

Researchers have discovered that xy018 exhibits remarkable potential in identifying previously undetectable molecular interactions, potentially revolutionizing precision medicine approaches in targeted therapeutic development.

Manufactured by WuXi AppTec

Visit Supplier

Sourced in United States

About the product

The XY018 is a lab equipment product designed for sample preparation and processing. It provides consistent and reliable performance for a variety of laboratory applications.

Automatically generated - may contain errors

Get Technical Specifications Find protocols

Lab products found in correlation

Gsk805, by WuXi AppTec (2 mentions) Tak828f, by WuXi AppTec (1 mentions) Vtp compound 23, by WuXi AppTec (1 mentions) Statin and other compounds, by Merck Group (1 mentions) Sr2211, by Bio-Techne (1 mentions) Ursolic acid, by Cayman Chemical (1 mentions) Digoxin, by Cayman Chemical (1 mentions)

Check compatibility

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

How does xy018 compare to similar analytical instruments in the research market?

What are the correct citation details for xy018 in scientific publications?

What laboratory systems and research platforms are compatible with xy018?

What primary research domains utilize xy018?

What unique scientific insight is associated with xy018?

4 protocols using «xy018»

Synthesis and Purchase of Compounds

2023

XY018 (purity >99%) was synthesized by WuXi AppTec. Ursolic acid (purity >95%) and digoxin (purity >98%) were purchased from Cayman.

Zou H., Yang Y, & Chen H.W. (2023). Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner. Frontiers in Pharmacology, 14, 1146741.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Synthesis and Sourcing of Compounds

2022

XY018 (Purity > 99%) was synthesized by WuXi AppTec (Austin, TX, USA). SR2211 (Purity > 98%) was obtained from TOCRIS (Bristol, UK). All statin and other compounds were obtained from Sigma-Aldrich (St. Louis, MO, USA), Selleck (Houston, TX, USA), or MedChemExpress (Monmouth Junction, NJ, USA).

Yang N., Yang Y., Huang Z, & Chen H.W. (2022). Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer. Cancers, 14(13), 3110.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Synthesis and Characterization of Novel Compounds

2022

Sources for chemicals are as follows: TAK828F, VTP compound 23 (VTP-23) [19 (link)], XY018 and GSK805 (purity > 99%) were synthesized by WuXi AppTec. Other chemicals (purity > 97%) are from Sigma and Cayman unless indicated otherwise.

Zou H., Yang Y., Shi Z., Wu X., Liu R., Yu A.M, & Chen H.W. (2022). Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy. Pharmacological research, 182, 106324.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Synthesis and Characterization of Novel Compounds

2019

Sources for chemicals are as follows: XY018 and GSK805 (purity > 99%) were synthesized by WuXi AppTec. Other chemicals (purity > 98%) are from Sigma and Selleck unless indicated otherwise.

Cai D., Wang J., Gao B., Li J., Wu F., Zou J.X., Xu J., Jiang Y., Zou H., Huang Z., Borowsky A.D., Bold R.J., Lara P.N., Li J.J., Chen X., Lam K.S., To K.F., Kung H.J., Fiehn O., Zhao R., Evans R.M, & Chen H.W. (2019). RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nature Communications, 10, 4621.

+ Open protocol

+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!